Squarepoint’s Teladoc Health TDOC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-34,000
| Closed | -$265K | – | 4990 |
|
|
2025
Q2 | $296K | Buy |
34,000
+100
| +0.3% | +$725 | ﹤0.01% | 3694 |
|
|
2025
Q1 | $270K | Buy |
+33,900
| New | +$343K | ﹤0.01% | 3814 |
|
|
2024
Q4 | – | Sell |
-244,318
| Closed | -$2.36M | – | 5489 |
|
|
2024
Q3 | $2.24M | Buy |
244,318
+133,209
| +120% | +$1.1M | ﹤0.01% | 1989 |
|
|
2024
Q2 | $1.09M | Buy |
+111,109
| New | +$1.36M | ﹤0.01% | 2495 |
|
|
2023
Q3 | – | Sell |
-194,718
| Closed | -$4.93M | – | 4238 |
|
|
2023
Q2 | $4.93M | Buy |
194,718
+133,584
| +219% | +$3.36M | 0.02% | 1089 |
|
|
2023
Q1 | $1.58M | Sell |
61,134
-183,329
| -75% | -$4.91M | 0.01% | 1577 |
|
|
2022
Q4 | $5.78M | Sell |
244,463
-229,298
| -48% | -$6.18M | 0.02% | 765 |
|
|
2022
Q3 | $12M | Buy |
473,761
+364,615
| +334% | +$12.8M | 0.06% | 365 |
|
|
2022
Q2 | $3.63M | Sell |
109,146
-592,548
| -84% | -$25.2M | 0.02% | 848 |
|
|
2022
Q1 | $50.6M | Buy |
701,694
+324,134
| +86% | +$23.4M | 0.22% | 88 |
|
|
2021
Q4 | $34.7M | Buy |
377,560
+177,266
| +89% | +$21.2M | 0.09% | 191 |
|
|
2021
Q3 | $25.4M | Buy |
200,294
+173,338
| +643% | +$25.2M | 0.07% | 240 |
|
|
2021
Q2 | $4.48M | Sell |
26,956
-89,647
| -77% | -$14.5M | 0.02% | 769 |
|
|
2021
Q1 | $21.2M | Buy |
116,603
+111,563
| +2,214% | +$25.9M | 0.12% | 172 |
|
|
2020
Q4 | $1.01M | Buy |
+5,040
| New | +$1.02M | 0.01% | 1327 |
|
|
2020
Q2 | – | Sell |
-3,596
| Closed | -$557K | – | 2509 |
|
|
2020
Q1 | $557K | Buy |
+3,596
| New | +$418K | 0.01% | 974 |
|
|
2019
Q2 | – | Sell |
-33,274
| Closed | -$1.85M | – | 2664 |
|
|
2019
Q1 | $1.85M | Buy |
33,274
+4,978
| +18% | +$304K | 0.02% | 804 |
|
|
2018
Q4 | $1.4M | Sell |
28,296
-7,945
| -22% | -$486K | 0.02% | 804 |
|
|
2018
Q3 | $3.13M | Buy |
36,241
+24,112
| +199% | +$1.72M | 0.04% | 564 |
|
|
2018
Q2 | $704K | Sell |
12,129
-14,471
| -54% | -$707K | 0.01% | 1035 |
|
|
2018
Q1 | $1.07M | Buy |
26,600
+5,689
| +27% | +$215K | 0.02% | 781 |
|
|
2017
Q4 | $729K | Buy |
+20,911
| New | +$694K | 0.01% | 979 |
|
|
2017
Q3 | – | Sell |
-10,400
| Closed | -$361K | – | 1873 |
|
|
2017
Q2 | $361K | Buy |
+10,400
| New | +$303K | 0.01% | 1070 |
|
Other funds holding TDOC
VPM
VCM
VC
Squarepoint's TDOC Position: Q3 2025 in Review
Squarepoint sold out of Teladoc Health (TDOC) in Q3 2025, closing a stake of 34,000 shares — an estimated $265K sold.
Squarepoint first reported a position in TDOC in Q2 2017 and held it in 23 quarters. The position peaked at $50.6M in Q1 2022. 355 funds tracked by Wall St. Rank hold TDOC as of Q3 2025.
- Squarepoint reported no remaining Teladoc Health position as of Q3 2025 after selling out during the quarter.
- Squarepoint sold 34,000 Teladoc Health shares in Q3 2025, an estimated $265K.
- Squarepoint first reported a position in Teladoc Health in Q2 2017 and held it in 23 quarters.
- Squarepoint's Teladoc Health position peaked at $50.6M in Q1 2022.
- 355 funds tracked by Wall St. Rank held Teladoc Health as of Q3 2025.
Based on Squarepoint's 13F filing for Q3 2025, filed 14 Nov 2025.